Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 17 | 2025 | 728 | 1.760 |
Why?
|
| Hypertension | 10 | 2025 | 817 | 0.870 |
Why?
|
| Mississippi | 24 | 2017 | 129 | 0.820 |
Why?
|
| Middle Aged | 59 | 2025 | 11790 | 0.780 |
Why?
|
| Blood Pressure | 11 | 2025 | 658 | 0.740 |
Why?
|
| Aged | 50 | 2025 | 7958 | 0.730 |
Why?
|
| Pharmacists | 2 | 2021 | 56 | 0.680 |
Why?
|
| Public Health Administration | 1 | 2020 | 26 | 0.660 |
Why?
|
| Adult | 51 | 2025 | 13437 | 0.650 |
Why?
|
| Workload | 1 | 2020 | 24 | 0.630 |
Why?
|
| Pharmacy | 1 | 2020 | 34 | 0.620 |
Why?
|
| Humans | 82 | 2025 | 42113 | 0.620 |
Why?
|
| Obesity | 7 | 2020 | 1129 | 0.600 |
Why?
|
| Female | 62 | 2025 | 23980 | 0.590 |
Why?
|
| Students, Pharmacy | 1 | 2020 | 57 | 0.580 |
Why?
|
| Male | 60 | 2025 | 22745 | 0.560 |
Why?
|
| Risk Factors | 25 | 2025 | 3933 | 0.560 |
Why?
|
| Tobacco Use Cessation | 1 | 2017 | 18 | 0.530 |
Why?
|
| Cholesterol, HDL | 4 | 2014 | 99 | 0.500 |
Why?
|
| Cohort Studies | 18 | 2025 | 1728 | 0.500 |
Why?
|
| Aged, 80 and over | 25 | 2021 | 2790 | 0.490 |
Why?
|
| Young Adult | 22 | 2021 | 4928 | 0.470 |
Why?
|
| Social Class | 6 | 2013 | 286 | 0.470 |
Why?
|
| Christianity | 1 | 2015 | 7 | 0.450 |
Why?
|
| Triglycerides | 4 | 2014 | 146 | 0.440 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2017 | 959 | 0.420 |
Why?
|
| United States | 12 | 2024 | 5068 | 0.400 |
Why?
|
| Insulin Resistance | 4 | 2012 | 199 | 0.390 |
Why?
|
| Diabetes Mellitus | 5 | 2015 | 531 | 0.390 |
Why?
|
| Prevalence | 12 | 2017 | 1593 | 0.390 |
Why?
|
| Body Mass Index | 10 | 2018 | 915 | 0.370 |
Why?
|
| Lung | 2 | 2014 | 484 | 0.360 |
Why?
|
| Coronary Artery Bypass | 3 | 2017 | 47 | 0.360 |
Why?
|
| Weight Loss | 2 | 2023 | 138 | 0.350 |
Why?
|
| Hormone Replacement Therapy | 1 | 2011 | 49 | 0.350 |
Why?
|
| Cross-Sectional Studies | 14 | 2025 | 3073 | 0.340 |
Why?
|
| Students | 1 | 2017 | 617 | 0.340 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 41 | 0.340 |
Why?
|
| Menopause | 1 | 2011 | 63 | 0.340 |
Why?
|
| Magnesium | 2 | 2021 | 93 | 0.340 |
Why?
|
| Louisiana | 5 | 2025 | 49 | 0.320 |
Why?
|
| Quality of Life | 2 | 2018 | 598 | 0.320 |
Why?
|
| Coronary Disease | 1 | 2010 | 123 | 0.310 |
Why?
|
| Biomedical Research | 3 | 2022 | 467 | 0.300 |
Why?
|
| Multivariate Analysis | 7 | 2020 | 637 | 0.300 |
Why?
|
| Life Style | 2 | 2023 | 326 | 0.300 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2015 | 45 | 0.300 |
Why?
|
| Health Promotion | 1 | 2015 | 691 | 0.290 |
Why?
|
| Environment | 1 | 2009 | 148 | 0.280 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 163 | 0.280 |
Why?
|
| Coronary Artery Disease | 3 | 2016 | 162 | 0.280 |
Why?
|
| Telemedicine | 2 | 2025 | 214 | 0.280 |
Why?
|
| Prospective Studies | 11 | 2019 | 1570 | 0.270 |
Why?
|
| Healthcare Disparities | 2 | 2025 | 570 | 0.270 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 225 | 0.260 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 5 | 2025 | 64 | 0.260 |
Why?
|
| Health Status Disparities | 6 | 2025 | 702 | 0.250 |
Why?
|
| Blood Glucose | 4 | 2014 | 386 | 0.250 |
Why?
|
| Cardiotonic Agents | 2 | 2017 | 39 | 0.240 |
Why?
|
| Sleep | 3 | 2021 | 179 | 0.230 |
Why?
|
| Respiratory Tract Diseases | 1 | 2025 | 30 | 0.230 |
Why?
|
| Erythrocyte Indices | 1 | 2025 | 14 | 0.230 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 121 | 0.220 |
Why?
|
| Narcotic Antagonists | 1 | 2025 | 78 | 0.220 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2025 | 52 | 0.220 |
Why?
|
| Buprenorphine | 1 | 2025 | 51 | 0.220 |
Why?
|
| Stress, Psychological | 4 | 2016 | 641 | 0.220 |
Why?
|
| Secondary Prevention | 1 | 2024 | 47 | 0.210 |
Why?
|
| Regression Analysis | 4 | 2020 | 487 | 0.210 |
Why?
|
| Erythrocytes | 1 | 2025 | 126 | 0.210 |
Why?
|
| Retrospective Studies | 8 | 2021 | 2466 | 0.210 |
Why?
|
| Recurrence | 1 | 2024 | 149 | 0.210 |
Why?
|
| Research Design | 5 | 2018 | 370 | 0.200 |
Why?
|
| Stroke | 2 | 2024 | 336 | 0.200 |
Why?
|
| Echocardiography | 4 | 2015 | 167 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 744 | 0.200 |
Why?
|
| Vaccination | 1 | 2025 | 332 | 0.200 |
Why?
|
| Exercise | 3 | 2020 | 674 | 0.190 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 268 | 0.190 |
Why?
|
| Minority Health | 2 | 2022 | 95 | 0.190 |
Why?
|
| Hospitalization | 2 | 2011 | 477 | 0.190 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 188 | 0.180 |
Why?
|
| Longitudinal Studies | 9 | 2018 | 1019 | 0.180 |
Why?
|
| Population Surveillance | 4 | 2014 | 245 | 0.180 |
Why?
|
| Adolescent | 8 | 2021 | 5949 | 0.180 |
Why?
|
| Program Development | 2 | 2015 | 237 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 470 | 0.170 |
Why?
|
| Pharmaceutical Services | 1 | 2021 | 23 | 0.170 |
Why?
|
| Intra-Abdominal Fat | 2 | 2012 | 45 | 0.170 |
Why?
|
| Insulin | 2 | 2012 | 255 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1679 | 0.160 |
Why?
|
| Genetic Loci | 2 | 2010 | 102 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2014 | 188 | 0.150 |
Why?
|
| Biostatistics | 1 | 2018 | 10 | 0.150 |
Why?
|
| Behavioral Research | 1 | 2019 | 41 | 0.150 |
Why?
|
| Calcium | 1 | 2021 | 487 | 0.140 |
Why?
|
| Primary Health Care | 2 | 2020 | 362 | 0.140 |
Why?
|
| C-Reactive Protein | 2 | 2010 | 164 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 11 | 0.140 |
Why?
|
| Urban Population | 2 | 2010 | 364 | 0.140 |
Why?
|
| Health Services Research | 1 | 2018 | 161 | 0.140 |
Why?
|
| Ghana | 4 | 2025 | 36 | 0.140 |
Why?
|
| Minority Groups | 2 | 2022 | 663 | 0.140 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 233 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2018 | 82 | 0.130 |
Why?
|
| Incidence | 4 | 2015 | 1052 | 0.130 |
Why?
|
| Circadian Rhythm | 3 | 2016 | 234 | 0.130 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 250 | 0.130 |
Why?
|
| Diastole | 2 | 2021 | 47 | 0.120 |
Why?
|
| Universities | 2 | 2017 | 539 | 0.120 |
Why?
|
| Sex Factors | 4 | 2012 | 1004 | 0.120 |
Why?
|
| Obesity, Abdominal | 2 | 2014 | 29 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2015 | 19 | 0.120 |
Why?
|
| Risk | 4 | 2018 | 288 | 0.120 |
Why?
|
| Cholesterol | 1 | 2017 | 230 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2025 | 844 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2017 | 253 | 0.110 |
Why?
|
| Organizational Objectives | 1 | 2015 | 33 | 0.110 |
Why?
|
| Rural Population | 3 | 2018 | 352 | 0.110 |
Why?
|
| Nicotine | 1 | 2017 | 290 | 0.110 |
Why?
|
| Insecticide-Treated Bednets | 1 | 2014 | 8 | 0.110 |
Why?
|
| Prognosis | 3 | 2015 | 847 | 0.110 |
Why?
|
| Health Surveys | 3 | 2014 | 401 | 0.110 |
Why?
|
| Personnel, Hospital | 1 | 2014 | 10 | 0.110 |
Why?
|
| Infant Care | 1 | 2014 | 6 | 0.110 |
Why?
|
| Mosquito Control | 1 | 2014 | 15 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 22 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 48 | 0.100 |
Why?
|
| Hypokalemia | 1 | 2013 | 11 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2013 | 15 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2021 | 1265 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2013 | 183 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 55 | 0.100 |
Why?
|
| Infant Mortality | 1 | 2014 | 64 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2013 | 31 | 0.100 |
Why?
|
| Proteinuria | 1 | 2013 | 55 | 0.100 |
Why?
|
| Chromosome Mapping | 2 | 2010 | 198 | 0.100 |
Why?
|
| Malaria | 1 | 2014 | 90 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2011 | 96 | 0.100 |
Why?
|
| Refusal to Participate | 1 | 2012 | 3 | 0.090 |
Why?
|
| Parenting | 1 | 2013 | 135 | 0.090 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2012 | 1 | 0.090 |
Why?
|
| Allostasis | 1 | 2012 | 22 | 0.090 |
Why?
|
| Nigeria | 2 | 2025 | 92 | 0.090 |
Why?
|
| Persuasive Communication | 1 | 2011 | 9 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2012 | 60 | 0.090 |
Why?
|
| Public Health Practice | 1 | 2011 | 39 | 0.090 |
Why?
|
| Spirometry | 1 | 2011 | 40 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 76 | 0.090 |
Why?
|
| Income | 1 | 2012 | 160 | 0.090 |
Why?
|
| Age Factors | 2 | 2012 | 1135 | 0.090 |
Why?
|
| Adiponectin | 1 | 2011 | 59 | 0.090 |
Why?
|
| Prejudice | 1 | 2012 | 116 | 0.090 |
Why?
|
| Disease Progression | 2 | 2015 | 660 | 0.090 |
Why?
|
| Motivation | 1 | 2015 | 492 | 0.080 |
Why?
|
| Models, Biological | 1 | 2014 | 710 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2011 | 66 | 0.080 |
Why?
|
| Educational Status | 1 | 2012 | 335 | 0.080 |
Why?
|
| Health Education | 1 | 2013 | 358 | 0.080 |
Why?
|
| Pericardium | 1 | 2010 | 15 | 0.080 |
Why?
|
| Health Status Indicators | 2 | 2007 | 90 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 56 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2011 | 225 | 0.080 |
Why?
|
| Research Personnel | 2 | 2022 | 191 | 0.080 |
Why?
|
| Geographic Information Systems | 1 | 2010 | 47 | 0.080 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 41 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 15 | 0.080 |
Why?
|
| Public Policy | 1 | 2009 | 36 | 0.080 |
Why?
|
| Professional Competence | 1 | 2009 | 42 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 140 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2013 | 410 | 0.070 |
Why?
|
| Health Services | 1 | 2009 | 62 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2009 | 73 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2009 | 48 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 111 | 0.070 |
Why?
|
| Workplace | 1 | 2009 | 86 | 0.070 |
Why?
|
| Attitude | 1 | 2009 | 108 | 0.070 |
Why?
|
| Phenotype | 2 | 2009 | 774 | 0.070 |
Why?
|
| Lipids | 1 | 2010 | 256 | 0.070 |
Why?
|
| Needs Assessment | 1 | 2010 | 178 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 1051 | 0.070 |
Why?
|
| Genome, Human | 1 | 2009 | 143 | 0.070 |
Why?
|
| Residence Characteristics | 3 | 2005 | 358 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 727 | 0.070 |
Why?
|
| Proteins | 1 | 2010 | 383 | 0.070 |
Why?
|
| Schools | 1 | 2009 | 283 | 0.070 |
Why?
|
| Health Behavior | 1 | 2011 | 568 | 0.060 |
Why?
|
| Health Literacy | 2 | 2020 | 120 | 0.060 |
Why?
|
| Systole | 2 | 2021 | 67 | 0.060 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 85 | 0.060 |
Why?
|
| Smoking | 1 | 2014 | 1019 | 0.060 |
Why?
|
| Waist Circumference | 3 | 2012 | 90 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2012 | 858 | 0.060 |
Why?
|
| Caribbean Region | 1 | 2025 | 75 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 42 | 0.050 |
Why?
|
| Laboratories | 1 | 2004 | 40 | 0.050 |
Why?
|
| Logistic Models | 3 | 2013 | 1001 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2024 | 73 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 437 | 0.050 |
Why?
|
| Feedback | 1 | 2023 | 55 | 0.050 |
Why?
|
| Genome-Wide Association Study | 3 | 2010 | 421 | 0.050 |
Why?
|
| Patient Selection | 1 | 2005 | 192 | 0.050 |
Why?
|
| Dementia | 1 | 2024 | 155 | 0.050 |
Why?
|
| Research | 1 | 2004 | 177 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 1221 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 106 | 0.050 |
Why?
|
| Depression | 2 | 2024 | 837 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2014 | 960 | 0.050 |
Why?
|
| Pregnancy | 3 | 2018 | 1733 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2012 | 162 | 0.040 |
Why?
|
| Focus Groups | 1 | 2023 | 398 | 0.040 |
Why?
|
| Actigraphy | 1 | 2021 | 17 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2013 | 224 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2020 | 23 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2023 | 523 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 115 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 1845 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 181 | 0.040 |
Why?
|
| Georgia | 1 | 2019 | 189 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 89 | 0.040 |
Why?
|
| Computers, Handheld | 1 | 2018 | 6 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2018 | 15 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 61 | 0.030 |
Why?
|
| Linear Models | 2 | 2009 | 310 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2018 | 47 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2019 | 187 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2017 | 10 | 0.030 |
Why?
|
| Genotype | 2 | 2011 | 792 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2011 | 427 | 0.030 |
Why?
|
| Patient Participation | 1 | 2018 | 87 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 430 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2018 | 137 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 1449 | 0.030 |
Why?
|
| Self Care | 1 | 2018 | 173 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 357 | 0.030 |
Why?
|
| Internet | 1 | 2018 | 234 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 62 | 0.030 |
Why?
|
| Comorbidity | 2 | 2011 | 723 | 0.030 |
Why?
|
| Child | 2 | 2014 | 3381 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 135 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 309 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 395 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2016 | 230 | 0.030 |
Why?
|
| Hospitals, District | 1 | 2014 | 2 | 0.030 |
Why?
|
| World Health Organization | 1 | 2014 | 36 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2013 | 30 | 0.030 |
Why?
|
| Maryland | 1 | 2014 | 61 | 0.030 |
Why?
|
| International Cooperation | 1 | 2014 | 51 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 61 | 0.030 |
Why?
|
| Inservice Training | 1 | 2014 | 33 | 0.030 |
Why?
|
| Insecticides | 1 | 2014 | 54 | 0.030 |
Why?
|
| Psychological Theory | 1 | 2013 | 25 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2014 | 62 | 0.020 |
Why?
|
| Cause of Death | 1 | 2014 | 183 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 175 | 0.020 |
Why?
|
| Child Development | 1 | 2013 | 95 | 0.020 |
Why?
|
| Social Support | 1 | 2016 | 437 | 0.020 |
Why?
|
| Mentors | 1 | 2014 | 143 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 1058 | 0.020 |
Why?
|
| Alleles | 1 | 2013 | 351 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2014 | 357 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 88 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 103 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 203 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 71 | 0.020 |
Why?
|
| Overweight | 1 | 2014 | 248 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2011 | 44 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 53 | 0.020 |
Why?
|
| Osteopetrosis | 1 | 1991 | 3 | 0.020 |
Why?
|
| Curriculum | 1 | 2013 | 311 | 0.020 |
Why?
|
| Body Composition | 1 | 2012 | 160 | 0.020 |
Why?
|
| Awareness | 1 | 2011 | 73 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 733 | 0.020 |
Why?
|
| Tibia | 1 | 1991 | 26 | 0.020 |
Why?
|
| Fasting | 1 | 2011 | 56 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 42 | 0.020 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2010 | 5 | 0.020 |
Why?
|
| Pregnancy, Multiple | 1 | 1990 | 6 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1142 | 0.020 |
Why?
|
| Twins | 1 | 1990 | 18 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 584 | 0.020 |
Why?
|
| Trust | 1 | 2012 | 157 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2010 | 30 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2010 | 34 | 0.020 |
Why?
|
| Fetal Blood | 1 | 1990 | 48 | 0.020 |
Why?
|
| Censuses | 1 | 2010 | 28 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 86 | 0.020 |
Why?
|
| Calcinosis | 1 | 2010 | 61 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2010 | 118 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 260 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 1515 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2009 | 26 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 144 | 0.020 |
Why?
|
| Albuminuria | 1 | 2010 | 78 | 0.020 |
Why?
|
| Demography | 1 | 2010 | 195 | 0.020 |
Why?
|
| Markov Chains | 1 | 2009 | 42 | 0.020 |
Why?
|
| Oxygen | 1 | 1990 | 217 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 244 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 250 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Health Status | 1 | 2012 | 432 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 335 | 0.020 |
Why?
|
| Software | 1 | 2010 | 234 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2010 | 164 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2009 | 429 | 0.020 |
Why?
|
| Psychometrics | 1 | 2007 | 350 | 0.010 |
Why?
|
| Heart Failure | 1 | 2009 | 298 | 0.010 |
Why?
|
| Research Subjects | 1 | 2005 | 34 | 0.010 |
Why?
|
| HIV Infections | 1 | 2012 | 2535 | 0.010 |
Why?
|
| Bone Resorption | 1 | 1991 | 22 | 0.010 |
Why?
|
| Osteoclasts | 1 | 1991 | 28 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1991 | 85 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1991 | 158 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 209 | 0.010 |
Why?
|
| Apgar Score | 1 | 1990 | 5 | 0.010 |
Why?
|
| Labor Presentation | 1 | 1990 | 3 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1990 | 12 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1990 | 63 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1991 | 574 | 0.000 |
Why?
|
| Mice | 1 | 1991 | 6490 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 16694 | 0.000 |
Why?
|